Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
2024 · Lung Cancer · 15 citations
https://doi.org/10.1016/j.lungcan.2024.107928
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
19
Citations
2
h-index
1
i10-index
Jun Vivien Yin is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Occupational and environmental lung diseases & Pleural and Pulmonary Diseases. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat